Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Dr. Reddy's Laboratories, Inc.
LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap p…
Alchemee, LLC
Chemical contamination: Presence of benzene
Alchemee, LLC
Chemical contamination: Presence of benzene
KABANA SKIN CARE
cGMP deviations
KABANA SKIN CARE
cGMP deviations
KABANA SKIN CARE
cGMP deviations
KABANA SKIN CARE
cGMP deviations
Fruit Of The Earth, Inc.
Chemical contamination: presence of benzene
FDC Limited
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Fruit Of The Earth, Inc.
Chemical contamination: presence of benzene
Glenmark Pharmaceuticals Inc., USA
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
Jamp Calcium Carbonate 500 + Vitamin D 1000 Tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Mylan Institutional, Inc.
Super-Potent Drug: Out of specification potency results were obtained.
Slate Run Pharmaceuticals
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Mylan Institutional, Inc.
Super-Potent Drug: Out of specification potency results were obtained.
Slate Run Pharmaceuticals
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Consumer Product Partners, LLC
Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol
Exela Pharma Sciences LLC
Lack of Assurance of Sterility
ASEGUA THERAPEUTICS LLC
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Direct Rx
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Direct Rx
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
QuVa Pharma, Inc.
Lack of Assurance of Sterility
QuVa Pharma, Inc.
Lack of Assurance of Sterility
QuVa Pharma, Inc.
Lack of Assurance of Sterility